However, a recent study suggests that IL-10 contributes to gemcitabine resistance in ENKTL cell lines by regulation of drug resistance genes, suggesting that inhibition of IL-10 in select patients may be utilized to increase tumor sensitivity to chemotherapy [113]. The gene discussed is IL10; the disease is neoplasm.